Oncimmune Holdings plc (LON:ONC – Get Free Report) shares dropped 8.5% during trading on Thursday . The stock traded as low as GBX 11.80 ($0.14) and last traded at GBX 11.90 ($0.15). Approximately 1,445,113 shares were traded during mid-day trading, an increase of 550% from the average daily volume of 222,310 shares. The stock had previously closed at GBX 13 ($0.16).
Oncimmune Stock Down 8.5 %
The stock has a market cap of £8.82 million, a price-to-earnings ratio of -396.67 and a beta of 1.19. The business’s 50 day moving average is GBX 14.83 and its 200-day moving average is GBX 14.72. The company has a debt-to-equity ratio of 806.85, a quick ratio of 0.63 and a current ratio of 1.13.
Oncimmune Company Profile
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Further Reading
- Five stocks we like better than Oncimmune
- Stock Market Sectors: What Are They and How Many Are There?
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- What Are Earnings Reports?
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Conference Calls and Individual Investors
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
